GSK Abreva Performance Claims Affirmed By NAD, Leave Novartis Sore

Advertising claims that GlaxoSmithKline's cold-sore treatment Abreva "speeds healing like a prescription without one" are supported, the National Advertising Division of the Council of Better Business Bureaus concludes after a recent inquiry